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Objective.Toidentifycorrelatesofincidentbacterialvaginosis(BV)diagnosedwithNugentscoringamonghigh-riskwomen.Study
Design. We conducted both cohort and case-crossover analyses, stratiﬁed by HIV infection status, based on 871 HIV-infected and
439 HIV-uninfected participants in the HIV Epidemiology Research Study, conducted in 4 US sites in 1993–2000. Results.B V
incidence was 21% and 19% among HIV-infected and -uninfected women, respectively. Fewer correlates of BV were found with
case-crossover than with cohort design. Reporting frequent coitus (regardless of consistency of condom use) was correlated with
BV in cohort analyses but not in case-crossover analyses. The sole correlate of BV in both types of analyses was the detection of
spermatozoa on Gram stain, which is a marker of semen exposure. Conclusion. The inconsistent association between condom use
and BV in prior studies could be from reporting bias. We found evidence of a relationship between semen exposure and incident
BV.
1.Introduction
Bacterial vaginosis (BV) is a common vaginal condition with
an estimated prevalence of 29% among U.S. women during
2001–2004 [1]. BV has been linked to a range of adverse
reproductive outcomes, including infertility, spontaneous
abortion, preterm premature rupture of the membranes,
amniotic ﬂuid infection, low birth weight, and preterm
delivery[2–8].BValsomightincreasewomen’sriskforpelvic
inﬂammatory disease although evidence on this possible
association is inconsistent [9–11]. In addition, evidence
suggests that BV increases women’s risk for sexually trans-
mitted infections (STIs), including gonorrhea, chlamydial
infection, trichomoniasis, human papillomavirus, herpes
simplex virus, and HIV [12–19].
Although the etiology of BV remains unknown, two
competing hypotheses currently prevail [20–22]. In the ﬁrst,
BV is viewed as an imbalance of the vaginal microbiota
caused by the colonization of endogenous organisms from
theintestinaltract[23].Thisimbalancecouldbeprecipitated
by a variety of events, including coitus and vaginal cleansing
or douching. The second hypothesis holds that BV is caused
by the sexual transmission of a speciﬁc pathogen (e.g.,
Gardnerella vaginalis or unknown bacteria). The similarity
between the epidemiology of BV and that of STIs supports
the hypothesis that BV is sexually transmitted. For example,
BVhasbeenassociatedwithriskysexualbehaviors,including
having new or a relatively high number of sexual partners,
having sex frequently, not using condoms, using drugs
during sex, and having sex with uncircumcised partners2 Infectious Diseases in Obstetrics and Gynecology
[1, 16, 22, 24, 25]. However, because these associations
often have been found in observational studies, they could
be the result of uncontrolled confounding. Use of a case-
crossover analysis (in which each woman serves as her own
control) would minimize the eﬀects of time-independent
confounders [25]. We conducted both cohort and case-
crossover analyses to identify time-variant correlates of BV
among a cohort of high-risk women in the U.S., who
participated in a longitudinal study of the eﬀects of HIV
infection on women’s health [26].
2.MaterialsandMethods
We analyzed data from the HIV Epidemiology Research
Study (HERS), which was conducted at 4 U.S. sites (Bronx,
NY; Detroit, MI; Baltimore, MD; and Providence, RI, USA)
in 1993–2000 [26]. Participants consisted of 871 HIV-
infected women and 439 uninfected women who, at the time
they enrolled in the study, were 16–55 years of age, did not
have an AIDS-deﬁning clinical diagnosis, and either injected
drugs or engaged in high-risk sexual behaviors (i.e., had >5
sexual partners in the previous 5 years, traded sex for money
or drugs, or had sex with a male who injected drugs or who
was suspected of being or known to be infected with HIV).
After enrollment, participants completed follow-up visits
scheduled at 6-month intervals. During these visits, HERS
staﬀ conducted interviews to collect demographic, health,
and behavioral information, conducted physical examina-
tions, and collected specimens to be tested for infections,
including BV, HIV, human papillomavirus (HPV), and
trichomoniasis. Study visits were not used to diagnose or
treat symptoms, and less than 1% of participants reported
using metronidazole or topical clindamycin [27]. Ethical
review boards at the study sites and the Centers for Disease
ControlandPreventionapprovedthestudy,andonlywomen
who gave informed consent were enrolled.
Gram-stained slides prepared from swabs of posterior
vaginal fornix specimens were air dried, ﬁxed in methanol,
and shipped to a central laboratory where a single technician
used oil immersion with ×1000 magniﬁcation to quantify
and score the specimens. Specimens with a Nugent score
of 7–10 were considered positive for BV [28]. Gram stains
also were evaluated for morphological identiﬁcation of
spermatozoa, which is speciﬁc for recent exposure to semen
[29]. Spermatozoa usually clear from vaginal secretions by
12–36 hours after exposure to semen although they have
been detected microscopically up to 10 days after exposure
[30,31].Wetmountwasusedfordiagnosingtrichomoniasis,
and vaginal specimens were cultured for Candida organisms.
Aliquots of cervicovaginal lavage ﬂuid were frozen for later
testing for HPV by polymerase chain reaction.
We limited our analyses to data collected during partic-
ipants’ ﬁrst 10 follow-up visits and excluded the 12 women
who HIV seroconverted during the study. Participants’
incident BV status was assessed at follow-up visits only if
Nugent scores of samples collected at their preceding visit
indicated that they were BV negative. If they tested positive
forBVortheirNugentscoresweremissing,theirincidentBV
status was coded as missing. We used unconditional (using
generalized estimating equations to account for intrasubject
correlation from multiple visits) and conditional logistic
regression to analyze the data as if they were derived from
a cohort and case-crossover study, respectively. For both
analyses, we constructed individual models to evaluate the
correlates of incident BV for HIV-infected and -uninfected
women separately. While the analytic population for the
cohort analysis included all follow-up visits with nonmissing
data on incident BV, the case-crossover analysis was limited
to follow-up visits from women who had ≥1 follow-up visit
with and ≥1 follow-up visit without incident BV.
For both the cohort and case-crossover analyses, we
ﬁtted individual models to assess the bivariable relationship
between each potential correlate and incident BV. For
the multivariable analyses, we ﬁtted full models with all
potential correlates and used manual, backward elimination
to exclude factors that were not signiﬁcantly associated
(based on an alpha of 0.05) with incident BV. Potential
correlates were selected because of their prior identiﬁcation
in the literature. The cohort analyses included both time-
independent and -dependent variables. However, because
individual participants in the case-crossover analyses served
both as case subjects and matching control subjects, the
variables evaluated in these analyses were limited to time-
dependent factors, which had the potential to vary between
the participant’s visits.
3. Results
Because of the diﬀerences in ﬁndings by HIV status in both
the cohort and case-crossover analyses, we present results
separately for HIV-infected and -uninfected participants.
The cohort analyses were based on data collected during
3,050 visits by 799 HIV-infected women and 1,564 visits
by 375 uninfected women. The case-crossover analyses were
based on data collected during 1,543 visits by 332 HIV-
infected women and 753 visits by 159 uninfected women.
The incidence of BV during the study follow-up period
was 21% among HIV-infected women and 19% among
uninfected women.
3.1. HIV-Infected Participants. The four time-independent
variables assessed (i.e., study site, age at baseline, race, and
education at baseline) were signiﬁcantly associated with
incident BV in the bivariable, cohort analyses among HIV-
infected women (Table 1). All variables except for study
site were also signiﬁcantly associated with incident BV in
the multivariable analysis, the results of which showed
risk for incident BV to be higher among women younger
than 45 years of age than among those older, higher
among black women than among white women, and higher
among women with a high-school education or less than
among those with post-high-school education. Seven time-
dependent variables were correlated with incident BV in the
bivariable, cohort analyses. Except for current injection drug
use and cigarette use within six months, these also were asso-
ciated with incident BV in the multivariable, cohort analysis.Infectious Diseases in Obstetrics and Gynecology 3
Table 1:ResultsofcohortanalysesofassociationsbetweenselectedfactorsandincidentbacterialvaginosisamongHIV-infectedU.S.women,
HERS, 1993–2000∗.
Control visits Case visits Bivariable model Multivariable model†
No. No. OR (95% CI) aOR (95% CI)
Time-independent factors
Study site
Site 1 749 138 Referent Referent
Site 2 502 170 1.8 (1.3, 2.4) 1.3 (0.9, 1.8)
Site 3 410 173 2.4 (1.7, 3.2) 1.4 (1.0, 2.0)
Site 4 761 147 1.1 (0.8, 1.5) 1.1 (0.8, 1.6)
Age at baseline (in years)
16–24 43 16 2.2 (1.1, 4.3) 1.4 (0.7, 3.0)
25–34 664 217 2.2 (1.6, 3.0) 2.0 (1.4, 2.8)
35–44 1235 324 1.7 (1.3, 2.3) 1.6 (1.2, 2.1)
45+ 480 71 Referent Referent
Race
Black 1239 430 2.1 (1.6, 2.6) 1.7 (1.3, 2.3)
Other 1183 198 Referent Referent
Education at baseline
<High school 906 289 1.8 (1.4, 2.4) 1.6 (1.2, 2.1)
High school 763 209 1.5 (1.2, 2.0) 1.5 (1.1, 1.9)
>High school 750 129 Referent Referent
Time-dependent factors
Visit (0–10) 0.9 (0.9, 1.0) 1.0 (0.9, 1.0)
CD4+ group (cells/µL)
0–199 567 147 1.0 (0.8, 1.3)
200–499 1213 308 1.1 (0.9, 1.5)
≥500 598 166 Referent
Trichomoniasis at preceding visit
Yes 180 117 2.2 (1.7, 2.8) 1.8 (1.4, 2.4)
No 2240 510 Referent Referent
Vaginal Candidal culture at preceding visit
Yes 804 247 1.2 (1.0, 1.4)
No 1612 377 Referent
Human papillomavirus at preceding visit
Yes 1468 432 1.3 (1.0, 1.5) 1.3 (1.0, 1.5)
No 934 188 Referent Referent
Spermatozoa detected on Gram stain
Yes 139 70 1.7 (1.3, 2.4) 1.5 (1.1, 2.1)
No 2283 558 Referent Referent
Sexual behavior during previous 6 months‡
Frequent coitus, inconsistent condom use 331 127 2.0 (1.6, 2.7) 1.6 (1.2, 2.2)
Frequent coitus, consistent condom use 431 146 1.8 (1.4, 2.4) 1.6 (1.2, 2.1)
Infrequent coitus, inconsistent condom use 240 65 1.4 (1.0, 1.9) 1.2 (0.9, 1.7)
Infrequent coitus, consistent condom use 488 127 1.4 (1.1, 1.8) 1.3 (1.0, 1.7)
Not sexually active 920 162 Referent Referent
Female sex partner during previous 6 months
Yes 86 25 1.1 (0.8, 1.7)
No 2320 601 Referent4 Infectious Diseases in Obstetrics and Gynecology
Table 1: Continued.
Control visits Case visits Bivariable model Multivariable model†
No. No. OR (95% CI) aOR (95% CI)
Douching within previous 48 hours
Yes 72 24 1.0 (0.6, 1.6)
No 2340 602 Referent
Current hormonal contraception use
Yes 101 29 1.2 (0.8, 1.8)
No 2319 599 Referent
Current injection drug use
Yes 304 131 1.7 (1.4, 2.2)
No 2114 497 Referent
Crack use during previous 6 months
Yes 199 117 2.2 (1.6, 2.9) 1.9 (1.4, 2.6)
No 2219 511 Referent Referent
Cigarette use during previous 6 months
Yes 1639 484 1.5 (1.2, 1.9)
No 779 144 Referent
HERS = HIV Epidemiology Research Study; OR: odds ratio; aOR: adjusted odds ratio; CI: conﬁdence interval.
∗Findings from unconditional logistic regression model, using generalized estimating equations, based on 628 case visits (i.e., visits with incident bacterial
vaginosis) and 2422 control visits (i.e., visits without incident bacterial vaginosis) completed by 799 participants.
†Adjusted for all variables in column.
‡Frequent coitus deﬁned as ≥4 times per month and infrequent coitus deﬁned as <4t i m e sp e rm o n t h .
Visits with trichomoniasis at the preceding visit (adjusted
odds ratio [aOR], 1.8; 95% conﬁdence interval [CI], 1.4–
2.4), HPV at the preceding visit (aOR, 1.3; 95%CI, 1.0–1.5),
and spermatozoa detected (aOR, 1.5; 95%CI, 1.1–2.1) had
more incident BV than visits without these diagnoses. Also,
visits in which the woman reported inconsistent condom use
andfrequent coitus(aOR,1.6; 95%CI, 1.2–2.2) orconsistent
condom use and frequent coitus (aOR, 1.6; 95%CI, 1.2–2.1)
were associated with more incident BV than visits in which
women reported no sexual activity. Finally, crack use within
six months correlated with incident BV (aOR, 1.9; 95%CI,
1.4–2.6).
The bivariable, case-crossover analyses yielded four
correlates of incident BV among HIV-infected women:
spermatozoa detection, sexual behaviors, current injection
drug use, and crack use within six months (Table 2). Except
for sexual behaviors, these variables remained signiﬁcantly
associatedinthemultivariable,case-crossoveranalysis.Visits
with spermatozoa detection (aOR, 1.6; 95%CI, 1.1–2.5),
reports of current injection drug use (aOR, 1.9; 95%CI, 1.1–
3.3) and reports of crack use within six months (aOR, 1.6;
95%CI, 1.0–2.7) were more likely to have incident BV than
visits without these factors.
3.2. HIV-Uninfected Participants. Among HIV-uninfected
participants, study site and race were the only time-
independent variables signiﬁcantly associated with BV risk
in the bivariable, cohort analyses, and both remained
signiﬁcantly associated with BV risk in the multivariable,
cohort analysis (Table 3). Black women had a higher risk
than women of other races (aOR, 1.9; 95%CI, 1.3–2.7).
Results of the bivariable, cohort analyses results showed
six time-dependent variables to be signiﬁcantly associated
with incident BV risk. All except one (crack use within the
previous 6 months) also were associated with BV risk in
the multivariable analyses. Factors signiﬁcantly associated
with incident BV risk in the multivariable analyses were
trichomoniasis at the preceding visit (aOR, 1.7; 95%CI, 1.1–
2.6), spermatozoa detection (aOR, 1.9; 95%CI, 1.3–2.9),
coitus ≥4 times per month during the previous 6 months
and either inconsistent condom use (aOR, 1.9; 95%CI, 1.3–
2.8) or consistent condom use (aOR, 1.9; 95%CI, 1.2–3.1)
cigarette use during previous 6 months (aOR, 1.5; 95%CI,
1.0–2.1), and current use of hormonal contraception (aOR,
0.4; 95% CI, 0.2–0.8).
Two factors were associated with incident BV in the
bivariable, case-crossover analyses among HIV-uninfected
participants, and both remained associated in the multivari-
ableanalysis(Table 4).Visitswithspermatozoadetectedwere
more likely to have incident BV (aOR, 2.1; 95%CI, 1.1–4.0)
than visits without its detection. Visits with self-reported
frequent coitus and either inconsistent condom use (aOR,
3.0; 95%CI, 1.5–5.9) or consistent condom use (aOR, 3.1;
95%CI, 1.3–7.4) had more incident BV than visits with self-
reported lack of sexual activity.
4. Discussion
The sole correlate of incident BV that emerged in both the
cohort and case-crossover analyses among HIV-infected and
-uninfected women was the detection of spermatozoa on
Gram stain, which is a biological marker of recent exposure
to semen. The cohort analyses among HIV-infected and
-uninfected women also found that incident BV was moreInfectious Diseases in Obstetrics and Gynecology 5
Table 2: Results of case-crossover analyses of associations between selected factors and incident bacterial vaginosis among HIV-infected U.S.
women, HERS, 1993–2000∗.
Control visits Case visits Bivariable model Multivariable model†
No. No. OR (95%CI) aOR (95%CI)
Time-dependent factors
CD4+ group (cells/µL)
0–199 257 112 0.8 (0.4, 1.3)
200–499 544 228 0.8 (0.5, 1.2)
≥500 249 128 Referent
Trichomoniasis at preceding visit
Positive 100 74 1.2 (0.8, 1.9)
Negative 967 400 Referent
Vaginal Candidal culture at preceding visit
Positive 371 181 1.1 (0.9, 1.5)
Negative 695 290 Referent
Human papillomavirus at preceding visit
Positive 668 326 0.8 (0.6, 1.2)
Negative 392 143 Referent
Spermatozoa detected on Gram stain
Yes 70 48 1.5 (1.0, 2.3) 1.6 (1.1, 2.5)
No 998 427 Referent Referent
Sexual behavior during previous 6 months‡
Frequent coitus, inconsistent condom use 151 92 1.9 (1.2, 3.1)
Frequent coitus, consistent condom use 177 113 1.7 (1.1, 2.8)
Infrequent coitus, inconsistent condom use 118 46 1.2 (0.7, 2.0)
Infrequent coitus, consistent condom use 225 96 1.2 (0.8, 1.8)
Not sexually active 388 127 Referent
Female sex partner during previous 6 months
Yes 51 20 1.5 (0.6, 3.9)
No 1010 453 Referent
Douching within 48 hours
Yes 38 19 0.7 (0.4, 1.3)
No 1025 454 Referent
Current hormonal contraception use
Yes 30 23 2.4 (0.9, 6.7)
No 1037 452 Referent
Current injection drug use
Yes 159 97 2.1 (1.2, 3.5) 1.9 (1.1, 3.3)
No 907 378 Referent Referent
Crack use during previous 6 months
Yes 107 81 1.8 (1.1, 2.9) 1.6 (1.0, 2.7)
No 959 394 Referent Referent
Cigarette use during previous 6 months
Yes 758 364 1.4 (0.7, 2.7)
No 308 111 Referent
∗Findings from conditional logistic regression model based on 475 case visits (i.e., visits with incident bacterial vaginosis) and 1068 control visits (i.e., visits
without incident bacterial vaginosis) completed by 332 women with at least one case and one control visit.
†Adjusted for all variables in column.
‡Frequent coitus deﬁned as ≥4 times per month and infrequent coitus deﬁned as <4t i m e sp e rm o n t h .6 Infectious Diseases in Obstetrics and Gynecology
Table 3: Results of cohort analyses of associations between selected factors and incident bacterial vaginosis among HIV-uninfected U.S.
women, HERS, 1993–2000∗.
Control visits Case visits Bivariable model Multivariable model†
No. No. OR (95% CI) aOR (95% CI)
Time-independent factors
Study site
Site 1 437 65 Referent Referent
Site 2 185 77 2.7 (1.7, 4.2) 1.9 (1.2, 3.1)
Site 3 271 94 2.4 (1.5, 3.7) 1.7 (1.0, 2.7)
Site 4 372 63 1.1 (0.7, 1.7) 1.5 (1.0, 2.3)
Age at baseline (in years)
16–24 51 7 0.9 (0.3, 2.1)
25–34 386 106 1.4 (0.9, 2.2)
35–44 597 139 1.1 (0.7, 1.6)
45+ 231 47 Referent
Race
Black 568 201 2.5 (1.8, 3.5) 1.9 (1.3, 2.7)
Other 697 98 Referent Referent
Education at baseline
<High school 367 99 1.4 (1.0, 2.1)
High school 436 101 1.1 (0.8, 1.6)
>High school 457 99 Referent
Time-dependent factors
Visit (0–15) 0.9 (0.9, 1.0) 0.94 (0.9, 1.0)
Trichomoniasis at preceding visit
Yes 100 60 2.1 (1.4, 3.2) 1.7 (1.1, 2.6)
No 1163 239 Referent Referent
Vaginal Candidal culture at preceding visit
Yes 393 91 1.0 (0.8, 1.3)
No 864 208 Referent
Human papillomavirus at preceding visit
Yes 278 84 1.3 (0.9, 1.7)
No 975 210 Referent
Spermatozoa detected on Gram stain
Yes 76 43 2.3 (1.6, 3.3) 1.9 (1.3, 2.9)
No 1189 256 Referent Referent
Sexual behavior during previous 6 months‡
Frequent coitus, inconsistent condom use 411 139 2.3 (1.6, 3.3) 1.9 (1.3, 2.8)
Frequent coitus, consistent condom use 129 35 1.8 (1.1, 2.9) 1.9 (1.2, 3.1)
Infrequent coitus, inconsistent condom use 244 49 1.4 (0.9, 2.0) 1.2 (0.8, 1.8)
Infrequent coitus, consistent condom use 138 23 1.1 (0.6, 1.9) 1.1 (0.6, 2.0)
Not sexually active 341 52 Referent Referent
Female sex partner during previous 6 months
Yes 92 25 1.2 (0.7, 1.8)
No 1169 272 Referent
Douching within 48 hours
Yes 44 13 1.1 (0.6, 2.0)
No 1215 285 Referent
Current hormonal contraception useInfectious Diseases in Obstetrics and Gynecology 7
Table 3: Continued.
Control visits Case visits Bivariable model Multivariable model†
No. No. OR (95% CI) aOR (95% CI)
Yes 92 9 0.4 (0.2, 0.9) 0.4 (0.2, 0.8)
No 1171 289 Referent Referent
Current injection drug use
Yes 160 58 1.5 (1.0, 2.2)
No 1104 241 Referent
Crack use during previous 6 months
Yes 139 66 2.0 (1.3, 2.9)
No 1125 233 Referent
Cigarette use during previous 6 months
Yes 837 230 1.7 (1.2, 2.4) 1.5 (1.0, 2.1)
No 427 69 Referent Referent
∗Findings from unconditional logistic regression model, using generalized estimating equations, based on 299 case visits (i.e., visits with incident bacterial
vaginosis) and 1265 control visits (i.e., visits without incident bacterial vaginosis) completed by 375 participants.
†Adjusted for all variables in column.
‡Frequent coitus deﬁned as ≥4 times per month and infrequent coitus deﬁned as <4t i m e sp e rm o n t h .
common among those reporting frequent coitus (regardless
of the consistency of condom use); however, this association
was not found in the case-crossover analyses. A protective
eﬀectofcondomsagainstBVhasbeendemonstratedinsome
prior studies (including a case-crossover analysis), but not
in all studies [22, 32–34]. The failure to ﬁnd a relationship
between condom use and decreased BV risk in earlier studies
could have been the result of misclassiﬁcation in participant
reporting of coitus and condom use. This misclassiﬁcation
could have occurred if studies collected inaccurate reports
of condom use, as a result of social desirability or recall
bias, or did not collect comprehensive data on condom
use, including possible malfunctions or misuse. A protective
eﬀe c to fc o n d o m sa g a i n s tB Va l s oc o u l dh a v eb e e no b s c u r e d
in previous studies because of the role of recurring cases of
BV. That is, if unprotected coitus can cause incident BV but
is not a necessary component for its recurrence, establishing
the link between unprotected coitus, and incident BV could
be diﬃcult.
We found fewer correlates of incident BV in our case-
crossover analyses than in our cohort analyses. Results of the
adjusted case-crossover analyses of incident BV among HIV-
infectedwomenshowedonlyspermatozoadetection,current
injection drug use, and crack use within the previous 6
months to be associated with incident BV, whereas results of
thecohortanalysesamongHIV-infectedwomenalsoshowed
trichomoniasis at the previous visit, HPV at the previous
visit and coitus ≥4 times per month during the previous
6 months to be associated with incident BV. Similarly,
results of the case-crossover analyses of risk among HIV-
uninfected women only found spermatozoa detection and
coitus ≥4 times per month during the previous 6 months
to be associated with incident BV, whereas results of the
cohort analyses among HIV-uninfected women also showed
trichomoniasis at the previous visit, current hormonal
contraception use, and cigarette use within the previous 6
monthstobeassociatedwithincidentBV.Thecase-crossover
analyses might have identiﬁed fewer correlates of incident
BV as a result of reduced confounding from each woman
serving as both a case subject (visits with incident BV) and
a matching control subject (visits without incident BV) [25].
Alternatively, reduced power in the case-crossover analyses
might have prevented the detection of correlates of BV.
A major study limitation was that BV was only assessed
at six-month intervals. Studies with frequent sampling have
suggested that women may have rapid ﬂuctuations in vaginal
microbiota, including short episodes of BV that resolve
spontaneously [35, 36]. Thus, our study might have missed
cases of BV. We were also unable to determine the temporal
relationship between exposure to semen and the develop-
ment of BV; as a result, we cannot rule out the possibility
that the association between the two factors is the result of
BVcausinglongerpersistenceofspermatozoainvaginalﬂuid
rather than semen exposure actually causing BV. Previous
case-crossover analyses also suggest that recent menses, use
of vaginal lubricants, rectal sex, douching for cleansing after
menstruation, and psychosocial stress could be risk factors
for incident BV [36–38]. None of these factors, though,
were evaluated in the present analysis. Finally, although the
detection of spermatozoa is speciﬁc for recent exposure to
semen, it is not a sensitive marker and cases of exposure
might have been missed [29, 39]. Strengths of our study
included our use of data from a large, prospective study in
which semen exposure was assessed by an objective measure
and our use of case-crossover analyses, which allowed us
to reduce possible eﬀects of unmeasured time-independent
confounding by comparing women to their own control
visits.
The detection of BV among women who have reported
being sexually abstinent has been an argument against the
role of sexual activity as a necessary component in causing
BV [40, 41]. However, results of a recent study among
young adults with a laboratory-diagnosed case of chlamydial
infection, gonorrhea, or trichomoniasis showed that 10%
reported having abstained from penile-vaginal intercourse
in the previous year and that 6% reported never having8 Infectious Diseases in Obstetrics and Gynecology
Table 4: Results of case-crossover analyses of associations between selected factors and incident bacterial vaginosis among HIV-uninfected
U.S. women, HERS, 1993–2000∗.
Control visits Case visits Bivariable model Multivariable model†
No. No. OR (95%CI) aOR (95%CI)
Time-dependent factors
Trichomoniasis at preceding visit
Yes 76 41 1.2 (0.7, 2.1)
No 446 189 Referent
Vaginal Candidal culture at preceding visit
Yes 143 70 1.1 (0.7, 1.6)
No 377 160 Referent
Human papillomavirus at preceding visit
Yes 126 55 1.0 (0.6, 1.5)
No 393 171 Referent
Spermatozoa detected on Gram stain
Yes 36 29 2.4 (1.3, 4.5) 2.1 (1.1, 4.0)
No 487 201 Referent Referent
Sexual behavior during previous 6 months‡
Frequent coitus, inconsistent condom use 159 100 3.3 (1.7, 6.6) 3.0 (1.5, 5.9)
Frequent coitus, consistent condom use 46 29 3.1 (1.3, 7.3) 3.1 (1.3, 7.4)
Infrequent coitus, inconsistent condom use 114 36 1.7 (0.8, 3.4) 1.6 (0.8, 3.2)
Infrequent coitus, consistent condom use 58 19 1.1 (0.5, 2.4) 1.1 (0.5, 2.5)
Not sexually active 145 45 Referent Referent
Female sex partner during previous 6 months
Yes 48 25 1.7 (0.6, 4.6)
No 472 204 Referent
Douching within 48 hours
Yes 23 10 0.8 (0.3, 2.2)
No 497 220 Referent
Current hormonal contraception use
Yes 22 8 0.4 (0.1, 1.3)
No 500 221 Referent
Current injection drug use
Yes 93 42 1.5 (0.7, 3.2)
No 429 188 Referent
Crack use during previous 6 months
Yes 93 45 1.4 (0.8, 2.5)
No 429 185 Referent
Cigarette use during previous 6 months
Yes 373 173 1.4 (0.6, 3.5)
No 149 57 Referent
∗Findings from conditional logistic regression model based on 230 case visits (i.e., visits with incident bacterial vaginosis) and 523 control visits (i.e., visits
without incident bacterial vaginosis) completed by 159 women with at least one case and one control visit.
†Adjusted for all variables in column.
‡Frequent coitus deﬁned as ≥4 times per month and infrequent coitus deﬁned as <4t i m e sp e rm o n t h .
had intercourse [42]. Thus, imperfect validity of self reports
could explain the occurrence of BV among women reporting
abstinence in prior studies. While study ﬁndings implicate
the role of sexual exposure in the development of incident
BV, this does not necessarily mean that BV is caused by the
transmission of speciﬁc organism(s) during intercourse.
Semen exposure could also increase women’s risk for
incident BV by increasing vaginal pH levels, changing the
growth patterns in bacteria populations, or exposing women
to an unidentiﬁed component of semen. The present studyInfectious Diseases in Obstetrics and Gynecology 9
found biological evidence of an association between semen
exposure and incident BV, which provides new support for
the sexual transmission of BV; however, the mechanism
remains unknown.
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